Julius Liobikas

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Survival of patients with glioblastoma remains within the range of several months despite advances in therapeutic options. We have already shown that 5-hydroxy-1,4-naphthalenedione (juglone) exerts antiproliferative, anti-invasive, and cytotoxic effects on glioma C6 cells. Here, we further revealed that juglone is relatively selective to glioma cells as(More)
  • 1